Abstract
Urine biomarkers for bladder cancer, explored in this chapter, assess their potential in enhancing diagnostic accuracy, monitoring recurrence, and improving surveillance protocols. The chapter discusses various biomarkers like EpiCheckTM, Xpert® Bladder Cancer Monitor, ADX BladderTM, and Cxbladder, evaluating their sensitivity and specificity for detecting high-grade tumors and their integration into clinical practice as adjuncts or alternatives to traditional methods like cystoscopy.

This publication has 14 references indexed in Scilit: